Compare BKTI & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BKTI | PEPG |
|---|---|---|
| Founded | 1997 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 332.2M | 353.9M |
| IPO Year | 2000 | 2022 |
| Metric | BKTI | PEPG |
|---|---|---|
| Price | $78.39 | $4.79 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $74.00 | $11.67 |
| AVG Volume (30 Days) | 36.2K | ★ 624.9K |
| Earning Date | 03-12-2026 | 03-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 52.89 | 25.61 |
| EPS | ★ 3.44 | N/A |
| Revenue | ★ $74,094,000.00 | N/A |
| Revenue This Year | $12.00 | N/A |
| Revenue Next Year | $11.30 | N/A |
| P/E Ratio | $23.19 | ★ N/A |
| Revenue Growth | ★ 45.42 | N/A |
| 52 Week Low | $28.35 | $0.89 |
| 52 Week High | $89.50 | $7.80 |
| Indicator | BKTI | PEPG |
|---|---|---|
| Relative Strength Index (RSI) | 43.93 | 38.34 |
| Support Level | $73.60 | $4.36 |
| Resistance Level | $87.21 | $5.50 |
| Average True Range (ATR) | 5.08 | 0.57 |
| MACD | -0.99 | -0.16 |
| Stochastic Oscillator | 48.42 | 6.07 |
BK Technologies Corp a holding company, operates through its subsidiary, BK Technologies, Inc., specializing in designing, manufacturing, and marketing wireless communications equipment. Its Radio business unit offers two-way land mobile radios (LMRs) serving government and public safety markets, as well as industrial and commercial enterprises. The SaaS business unit focuses on public safety smartphone applications, enhancing first responders' safety and efficiency. The BKRplay application, tethered to BK radios, amplifies user capabilities, expanding the reach of their radio sales. Its product portfolio consists of two-way land mobile radios, handheld radios, radios installed in vehicles.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed that their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle, and the central nervous system. Its pipeline products are: PGN-EDO51, PGN-EDODM1, and others.